The future of biopharmaceutical process development is driven by in silico solutions. We provide the tools to master the transition to bioprocessing 4.0.
GoSilico GmbH, now part of Cytiva, accelerates downstream process development with computer simulation.
Cytiva acquired GoSilico in June 2021 to strengthen digital capabilities in bioprocessing. Together, we can offer well proven mechanistic modeling expertise supported by decades of experience in developing chromatography processes. Our synchronized solutions for high quality mechanistic modeling enable faster process development and an improved manufacturing process.
Our disruptive simulation software DSPX enables the computer-based development and simulation of downstream processes. Benefit from the technology and digitalize your downstream process development!